nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Progesterone—uterine cancer	0.105	0.174	CbGbCtD
Reboxetine—CYP2D6—Progesterone—uterine cancer	0.0991	0.164	CbGbCtD
Reboxetine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0951	0.158	CbGbCtD
Reboxetine—ABCB1—Dactinomycin—uterine cancer	0.0834	0.138	CbGbCtD
Reboxetine—CYP3A4—Progesterone—uterine cancer	0.063	0.105	CbGbCtD
Reboxetine—ABCB1—Etoposide—uterine cancer	0.0471	0.0781	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—uterine cancer	0.0321	0.0533	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—uterine cancer	0.0303	0.0502	CbGbCtD
Reboxetine—CYP3A4—Etoposide—uterine cancer	0.0282	0.0468	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—uterine cancer	0.0192	0.0319	CbGbCtD
Reboxetine—Mental disability—Epirubicin—uterine cancer	0.000574	0.00145	CcSEcCtD
Reboxetine—Diarrhoea—Progesterone—uterine cancer	0.000563	0.00142	CcSEcCtD
Reboxetine—Anorexia—Dactinomycin—uterine cancer	0.000555	0.0014	CcSEcCtD
Reboxetine—Eye disorder—Etoposide—uterine cancer	0.000554	0.00139	CcSEcCtD
Reboxetine—Cardiac disorder—Etoposide—uterine cancer	0.00055	0.00139	CcSEcCtD
Reboxetine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.00138	CcSEcCtD
Reboxetine—Dizziness—Progesterone—uterine cancer	0.000544	0.00137	CcSEcCtD
Reboxetine—Angiopathy—Etoposide—uterine cancer	0.000538	0.00135	CcSEcCtD
Reboxetine—Immune system disorder—Etoposide—uterine cancer	0.000535	0.00135	CcSEcCtD
Reboxetine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000535	0.00135	CcSEcCtD
Reboxetine—Mediastinal disorder—Etoposide—uterine cancer	0.000534	0.00135	CcSEcCtD
Reboxetine—Chills—Etoposide—uterine cancer	0.000532	0.00134	CcSEcCtD
Reboxetine—Mental disability—Doxorubicin—uterine cancer	0.000531	0.00134	CcSEcCtD
Reboxetine—Vomiting—Progesterone—uterine cancer	0.000524	0.00132	CcSEcCtD
Reboxetine—Rash—Progesterone—uterine cancer	0.000519	0.00131	CcSEcCtD
Reboxetine—Dermatitis—Progesterone—uterine cancer	0.000519	0.00131	CcSEcCtD
Reboxetine—Headache—Progesterone—uterine cancer	0.000516	0.0013	CcSEcCtD
Reboxetine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00051	0.00129	CcSEcCtD
Reboxetine—Decreased appetite—Dactinomycin—uterine cancer	0.000506	0.00127	CcSEcCtD
Reboxetine—Dysgeusia—Etoposide—uterine cancer	0.000505	0.00127	CcSEcCtD
Reboxetine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.00124	CcSEcCtD
Reboxetine—Nausea—Progesterone—uterine cancer	0.000489	0.00123	CcSEcCtD
Reboxetine—Hyponatraemia—Epirubicin—uterine cancer	0.000482	0.00121	CcSEcCtD
Reboxetine—Diplopia—Epirubicin—uterine cancer	0.00048	0.00121	CcSEcCtD
Reboxetine—Feeling abnormal—Dactinomycin—uterine cancer	0.00048	0.00121	CcSEcCtD
Reboxetine—Ill-defined disorder—Etoposide—uterine cancer	0.000479	0.00121	CcSEcCtD
Reboxetine—Anaemia—Etoposide—uterine cancer	0.000477	0.0012	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000476	0.0012	CcSEcCtD
Reboxetine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000474	0.00119	CcSEcCtD
Reboxetine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00118	CcSEcCtD
Reboxetine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00118	CcSEcCtD
Reboxetine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.00118	CcSEcCtD
Reboxetine—Malaise—Etoposide—uterine cancer	0.000465	0.00117	CcSEcCtD
Reboxetine—Face oedema—Epirubicin—uterine cancer	0.000464	0.00117	CcSEcCtD
Reboxetine—Vertigo—Etoposide—uterine cancer	0.000464	0.00117	CcSEcCtD
Reboxetine—Leukopenia—Etoposide—uterine cancer	0.000462	0.00116	CcSEcCtD
Reboxetine—Body temperature increased—Dactinomycin—uterine cancer	0.00046	0.00116	CcSEcCtD
Reboxetine—Abdominal pain—Dactinomycin—uterine cancer	0.00046	0.00116	CcSEcCtD
Reboxetine—Loss of consciousness—Etoposide—uterine cancer	0.000454	0.00114	CcSEcCtD
Reboxetine—Blood creatinine increased—Epirubicin—uterine cancer	0.00045	0.00113	CcSEcCtD
Reboxetine—Dehydration—Epirubicin—uterine cancer	0.000447	0.00112	CcSEcCtD
Reboxetine—Hyponatraemia—Doxorubicin—uterine cancer	0.000446	0.00112	CcSEcCtD
Reboxetine—Hypertension—Etoposide—uterine cancer	0.000446	0.00112	CcSEcCtD
Reboxetine—Diplopia—Doxorubicin—uterine cancer	0.000444	0.00112	CcSEcCtD
Reboxetine—Liver function test abnormal—Epirubicin—uterine cancer	0.000443	0.00112	CcSEcCtD
Reboxetine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00112	CcSEcCtD
Reboxetine—Chest pain—Etoposide—uterine cancer	0.000439	0.00111	CcSEcCtD
Reboxetine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000439	0.0011	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000436	0.0011	CcSEcCtD
Reboxetine—Discomfort—Etoposide—uterine cancer	0.000434	0.00109	CcSEcCtD
Reboxetine—Breast disorder—Epirubicin—uterine cancer	0.000434	0.00109	CcSEcCtD
Reboxetine—Face oedema—Doxorubicin—uterine cancer	0.000429	0.00108	CcSEcCtD
Reboxetine—Hypersensitivity—Dactinomycin—uterine cancer	0.000429	0.00108	CcSEcCtD
Reboxetine—Confusional state—Etoposide—uterine cancer	0.000425	0.00107	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000424	0.00107	CcSEcCtD
Reboxetine—Muscular weakness—Epirubicin—uterine cancer	0.000424	0.00107	CcSEcCtD
Reboxetine—Infection—Etoposide—uterine cancer	0.000418	0.00105	CcSEcCtD
Reboxetine—Asthenia—Dactinomycin—uterine cancer	0.000418	0.00105	CcSEcCtD
Reboxetine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000416	0.00105	CcSEcCtD
Reboxetine—Influenza—Epirubicin—uterine cancer	0.000415	0.00105	CcSEcCtD
Reboxetine—Dehydration—Doxorubicin—uterine cancer	0.000413	0.00104	CcSEcCtD
Reboxetine—Tachycardia—Etoposide—uterine cancer	0.000411	0.00103	CcSEcCtD
Reboxetine—Liver function test abnormal—Doxorubicin—uterine cancer	0.00041	0.00103	CcSEcCtD
Reboxetine—Skin disorder—Etoposide—uterine cancer	0.000409	0.00103	CcSEcCtD
Reboxetine—Hyperhidrosis—Etoposide—uterine cancer	0.000407	0.00103	CcSEcCtD
Reboxetine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000406	0.00102	CcSEcCtD
Reboxetine—Breast disorder—Doxorubicin—uterine cancer	0.000402	0.00101	CcSEcCtD
Reboxetine—Anorexia—Etoposide—uterine cancer	0.000401	0.00101	CcSEcCtD
Reboxetine—Bronchitis—Epirubicin—uterine cancer	0.000399	0.00101	CcSEcCtD
Reboxetine—Diarrhoea—Dactinomycin—uterine cancer	0.000398	0.001	CcSEcCtD
Reboxetine—Hypotension—Etoposide—uterine cancer	0.000394	0.000991	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—uterine cancer	0.000392	0.000987	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000392	0.000987	CcSEcCtD
Reboxetine—Dysuria—Epirubicin—uterine cancer	0.000388	0.000977	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—uterine cancer	0.000384	0.000967	CcSEcCtD
Reboxetine—Pollakiuria—Epirubicin—uterine cancer	0.000384	0.000966	CcSEcCtD
Reboxetine—Paraesthesia—Etoposide—uterine cancer	0.000378	0.000952	CcSEcCtD
Reboxetine—Weight decreased—Epirubicin—uterine cancer	0.000376	0.000946	CcSEcCtD
Reboxetine—Dyspnoea—Etoposide—uterine cancer	0.000376	0.000945	CcSEcCtD
Reboxetine—Hyperglycaemia—Epirubicin—uterine cancer	0.000375	0.000943	CcSEcCtD
Reboxetine—Somnolence—Etoposide—uterine cancer	0.000374	0.000943	CcSEcCtD
Reboxetine—Infestation—Epirubicin—uterine cancer	0.00037	0.000932	CcSEcCtD
Reboxetine—Infestation NOS—Epirubicin—uterine cancer	0.00037	0.000932	CcSEcCtD
Reboxetine—Vomiting—Dactinomycin—uterine cancer	0.00037	0.000932	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—uterine cancer	0.000369	0.00093	CcSEcCtD
Reboxetine—Rash—Dactinomycin—uterine cancer	0.000367	0.000924	CcSEcCtD
Reboxetine—Decreased appetite—Etoposide—uterine cancer	0.000366	0.000922	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000364	0.000916	CcSEcCtD
Reboxetine—Constipation—Etoposide—uterine cancer	0.00036	0.000907	CcSEcCtD
Reboxetine—Conjunctivitis—Epirubicin—uterine cancer	0.00036	0.000906	CcSEcCtD
Reboxetine—Urinary tract infection—Epirubicin—uterine cancer	0.00036	0.000906	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—uterine cancer	0.000359	0.000904	CcSEcCtD
Reboxetine—Sweating—Epirubicin—uterine cancer	0.000355	0.000894	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—uterine cancer	0.000355	0.000893	CcSEcCtD
Reboxetine—Epistaxis—Epirubicin—uterine cancer	0.000349	0.000879	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—uterine cancer	0.000348	0.000875	CcSEcCtD
Reboxetine—Sinusitis—Epirubicin—uterine cancer	0.000347	0.000874	CcSEcCtD
Reboxetine—Feeling abnormal—Etoposide—uterine cancer	0.000347	0.000874	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000347	0.000872	CcSEcCtD
Reboxetine—Nausea—Dactinomycin—uterine cancer	0.000346	0.00087	CcSEcCtD
Reboxetine—Gastrointestinal pain—Etoposide—uterine cancer	0.000344	0.000867	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—uterine cancer	0.000343	0.000862	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—uterine cancer	0.000343	0.000862	CcSEcCtD
Reboxetine—Bradycardia—Epirubicin—uterine cancer	0.000338	0.000852	CcSEcCtD
Reboxetine—Urticaria—Etoposide—uterine cancer	0.000335	0.000842	CcSEcCtD
Reboxetine—Rhinitis—Epirubicin—uterine cancer	0.000333	0.000839	CcSEcCtD
Reboxetine—Abdominal pain—Etoposide—uterine cancer	0.000333	0.000838	CcSEcCtD
Reboxetine—Body temperature increased—Etoposide—uterine cancer	0.000333	0.000838	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—uterine cancer	0.000333	0.000838	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—uterine cancer	0.000333	0.000838	CcSEcCtD
Reboxetine—Pharyngitis—Epirubicin—uterine cancer	0.00033	0.00083	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—uterine cancer	0.000328	0.000827	CcSEcCtD
Reboxetine—Urinary tract disorder—Epirubicin—uterine cancer	0.000328	0.000826	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—uterine cancer	0.000327	0.000822	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—uterine cancer	0.000326	0.00082	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—uterine cancer	0.000323	0.000813	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—uterine cancer	0.000321	0.000809	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—uterine cancer	0.00032	0.000806	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—uterine cancer	0.000313	0.000788	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—uterine cancer	0.000311	0.000782	CcSEcCtD
Reboxetine—Hypersensitivity—Etoposide—uterine cancer	0.00031	0.000781	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—uterine cancer	0.00031	0.00078	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—uterine cancer	0.000308	0.000777	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—uterine cancer	0.000308	0.000776	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—uterine cancer	0.000305	0.000768	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000304	0.000765	CcSEcCtD
Reboxetine—Asthenia—Etoposide—uterine cancer	0.000302	0.000761	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000302	0.000761	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—uterine cancer	0.000302	0.000759	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—uterine cancer	0.000301	0.000759	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—uterine cancer	0.0003	0.000756	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—uterine cancer	0.0003	0.000754	CcSEcCtD
Reboxetine—Chills—Epirubicin—uterine cancer	0.000298	0.000751	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—uterine cancer	0.000296	0.000746	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—uterine cancer	0.000291	0.000733	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—uterine cancer	0.000289	0.000728	CcSEcCtD
Reboxetine—Diarrhoea—Etoposide—uterine cancer	0.000288	0.000726	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—uterine cancer	0.000287	0.000723	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—uterine cancer	0.000287	0.000722	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—uterine cancer	0.000285	0.000718	CcSEcCtD
Reboxetine—Tension—Epirubicin—uterine cancer	0.000284	0.000715	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—uterine cancer	0.000283	0.000713	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—uterine cancer	0.000281	0.000707	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—uterine cancer	0.000279	0.000702	CcSEcCtD
Reboxetine—Dizziness—Etoposide—uterine cancer	0.000279	0.000701	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—uterine cancer	0.000278	0.000699	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000277	0.000698	CcSEcCtD
Reboxetine—Chills—Doxorubicin—uterine cancer	0.000276	0.000695	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—uterine cancer	0.000269	0.000678	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—uterine cancer	0.000268	0.000676	CcSEcCtD
Reboxetine—Vomiting—Etoposide—uterine cancer	0.000268	0.000674	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—uterine cancer	0.000268	0.000674	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—uterine cancer	0.000267	0.000673	CcSEcCtD
Reboxetine—Agitation—Epirubicin—uterine cancer	0.000266	0.000669	CcSEcCtD
Reboxetine—Rash—Etoposide—uterine cancer	0.000266	0.000669	CcSEcCtD
Reboxetine—Dermatitis—Etoposide—uterine cancer	0.000265	0.000668	CcSEcCtD
Reboxetine—Headache—Etoposide—uterine cancer	0.000264	0.000664	CcSEcCtD
Reboxetine—Tension—Doxorubicin—uterine cancer	0.000263	0.000661	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—uterine cancer	0.000262	0.00066	CcSEcCtD
Reboxetine—Malaise—Epirubicin—uterine cancer	0.000261	0.000657	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—uterine cancer	0.00026	0.000655	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—uterine cancer	0.00026	0.000654	CcSEcCtD
Reboxetine—Syncope—Epirubicin—uterine cancer	0.000259	0.000653	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—uterine cancer	0.000259	0.000652	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—uterine cancer	0.000256	0.000644	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—uterine cancer	0.000254	0.00064	CcSEcCtD
Reboxetine—Nausea—Etoposide—uterine cancer	0.00025	0.00063	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—uterine cancer	0.00025	0.000629	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000248	0.000625	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—uterine cancer	0.000247	0.000623	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—uterine cancer	0.000246	0.00062	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—uterine cancer	0.000246	0.000619	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—uterine cancer	0.000245	0.000618	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000245	0.000616	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—uterine cancer	0.000243	0.000613	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—uterine cancer	0.000241	0.000608	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—uterine cancer	0.000241	0.000606	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—uterine cancer	0.00024	0.000605	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—uterine cancer	0.00024	0.000604	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—uterine cancer	0.00024	0.000603	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—uterine cancer	0.000238	0.000599	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—uterine cancer	0.000237	0.000596	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—uterine cancer	0.000235	0.000592	CcSEcCtD
Reboxetine—Infection—Epirubicin—uterine cancer	0.000235	0.000591	CcSEcCtD
Reboxetine—Shock—Epirubicin—uterine cancer	0.000232	0.000585	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—uterine cancer	0.000232	0.000583	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—uterine cancer	0.000231	0.000582	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—uterine cancer	0.00023	0.00058	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—uterine cancer	0.000229	0.000577	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—uterine cancer	0.000228	0.000575	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—uterine cancer	0.000228	0.000574	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—uterine cancer	0.000227	0.000572	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000226	0.00057	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—uterine cancer	0.000225	0.000567	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—uterine cancer	0.000225	0.000567	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—uterine cancer	0.000223	0.000561	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—uterine cancer	0.000221	0.000555	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—uterine cancer	0.00022	0.000555	CcSEcCtD
Reboxetine—Infection—Doxorubicin—uterine cancer	0.000217	0.000546	CcSEcCtD
Reboxetine—Shock—Doxorubicin—uterine cancer	0.000215	0.000541	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—uterine cancer	0.000214	0.000539	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—uterine cancer	0.000214	0.000538	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—uterine cancer	0.000213	0.000537	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—uterine cancer	0.000212	0.000534	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—uterine cancer	0.000212	0.000534	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000211	0.000532	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—uterine cancer	0.00021	0.00053	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—uterine cancer	0.00021	0.000528	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—uterine cancer	0.000208	0.000524	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—uterine cancer	0.000208	0.000523	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—uterine cancer	0.000205	0.000517	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—uterine cancer	0.000204	0.000514	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000204	0.000513	CcSEcCtD
Reboxetine—Constipation—Epirubicin—uterine cancer	0.000202	0.000508	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—uterine cancer	0.000198	0.000497	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—uterine cancer	0.000196	0.000494	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—uterine cancer	0.000195	0.00049	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—uterine cancer	0.000195	0.00049	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—uterine cancer	0.000194	0.000489	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000193	0.000486	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—uterine cancer	0.000192	0.000484	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—uterine cancer	0.00019	0.000478	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000189	0.000475	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—uterine cancer	0.000188	0.000472	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—uterine cancer	0.000187	0.00047	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—uterine cancer	0.000187	0.00047	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—uterine cancer	0.000187	0.00047	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—uterine cancer	0.00018	0.000453	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000179	0.00045	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—uterine cancer	0.000174	0.000438	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—uterine cancer	0.000174	0.000437	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—uterine cancer	0.000173	0.000435	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—uterine cancer	0.000173	0.000435	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—uterine cancer	0.000169	0.000426	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—uterine cancer	0.000162	0.000407	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—uterine cancer	0.000161	0.000405	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—uterine cancer	0.000157	0.000395	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—uterine cancer	0.000156	0.000393	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—uterine cancer	0.00015	0.000378	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—uterine cancer	0.000149	0.000376	CcSEcCtD
Reboxetine—Rash—Epirubicin—uterine cancer	0.000149	0.000375	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—uterine cancer	0.000149	0.000374	CcSEcCtD
Reboxetine—Headache—Epirubicin—uterine cancer	0.000148	0.000372	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—uterine cancer	0.000144	0.000364	CcSEcCtD
Reboxetine—Nausea—Epirubicin—uterine cancer	0.00014	0.000353	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—uterine cancer	0.000139	0.00035	CcSEcCtD
Reboxetine—Rash—Doxorubicin—uterine cancer	0.000138	0.000347	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—uterine cancer	0.000138	0.000346	CcSEcCtD
Reboxetine—Headache—Doxorubicin—uterine cancer	0.000137	0.000345	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—uterine cancer	0.00013	0.000327	CcSEcCtD
